Ironshore Therapeutics Inc., also known as Highland Therapeutics, is a prominent biopharmaceutical company headquartered in California. Founded in 2015, the company has rapidly established itself within the pharmaceutical industry, focusing on innovative treatments for central nervous system disorders. Ironshore's core offerings include its proprietary drug delivery technologies, which enhance the efficacy and tolerability of existing medications. This unique approach positions the company as a leader in the development of therapies for conditions such as attention deficit hyperactivity disorder (ADHD). With a commitment to advancing patient care, Ironshore Therapeutics has achieved significant milestones, including successful clinical trials and partnerships that bolster its market presence. The company continues to make strides in the biopharmaceutical landscape, driven by its dedication to innovation and patient-centric solutions.
We don't have data for Ironshore Therapeutics Inc., but we can show you information about their parent organization instead.
View parent company